Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?

Skip to the main content

Reumatizam, Vol. 72 No. Supp 1, 2025.

Meeting abstract

https://doi.org/10.33004/reumatizam-supp-72-1-82

Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?

Tanja Tatalović *
Felina Anić
Srđan Novak

* Corresponding author.

Full text: croatian pdf 651 Kb

page 92-92

downloads: 75

APA 6th Edition

Tatalović, T., Anić, F. & Novak, S. (2025). Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?. Reumatizam, 72 (Supp 1), 92-92. https://doi.org/10.33004/reumatizam-supp-72-1-82

MLA 8th Edition

Tatalović, Tanja, et al. "Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?." Reumatizam, vol. 72, no. Supp 1, 2025, pp. 92-92. https://doi.org/10.33004/reumatizam-supp-72-1-82. Accessed 13 May 2026.

Chicago 17th Edition

Tatalović, Tanja, Felina Anić and Srđan Novak. "Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?." Reumatizam 72, no. Supp 1 (2025): 92-92. https://doi.org/10.33004/reumatizam-supp-72-1-82

Harvard

Tatalović, T., Anić, F., and Novak, S. (2025). 'Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?', Reumatizam, 72(Supp 1), pp. 92-92. https://doi.org/10.33004/reumatizam-supp-72-1-82

Vancouver

Tatalović T, Anić F, Novak S. Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?. Reumatizam [Internet]. 2025 [cited 2026 May 13];72(Supp 1):92-92. https://doi.org/10.33004/reumatizam-supp-72-1-82

IEEE

T. Tatalović, F. Anić and S. Novak, "Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?", Reumatizam, vol.72, no. Supp 1, pp. 92-92, 2025. [Online]. https://doi.org/10.33004/reumatizam-supp-72-1-82

Abstract

Keywords

Hrčak ID:

339974

URI

https://hrcak.srce.hr/339974

Publication date:

5.11.2025.

Article data in other languages: croatian

Visits: 478 *